Details:

Alternative Title:
Emerg Infect Dis
Personal Author:
Meeuse, Jan J. ; Sprenger, Herman G. ; van Assen, Sander ; Leduc, Dominique ; Daenen, Simon M.G.J. ; ... More +
Meeuse, Jan J. ; Sprenger, Herman G. ; van Assen, Sander ; Leduc, Dominique ; Daenen, Simon M.G.J. ; Arends, Jan P. ; van der Werf, Tjip S. Less -
Description:
Rhodococcus equi, mainly known from veterinary medicine as a pathogen in domestic animals, can also cause infections in immunocompromised humans, especially in those with defects in cellular immunity. Alemtuzumab, an anti-CD52 monoclonal antibody, causes lymphocytopenia by eliminating CD52-positive cells. We report a patient in whom Rhodococcus equi infection developed after alemtuzumab therapy.
Subject:
[+]
Actinomycetales Infections
Aged
Alemtuzumab
Anti-Bacterial Agents
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Neoplasm
Antineoplastic Agents
Dispatch
Humans
Immunocompromised Host
Leukemia, Prolymphocytic, T-Cell
Lung Abscess
Male
Rhodococcus Equi
T-PLL

Source:
Emerg Infect Dis. 13(12):1942-1943.
Document Type:
Journal Article
Collection(s):
Emerging Infectious Diseases
Main Document Checksum:
[+]
urn:sha256:6152623f1224a44873922ae94e85c56b572374c75a3a5a7242cf2a24a6a6e2ca
File Type:

Supporting Files

• 	06-1559_finalD.nxml	txt
  	license.txt	txt

More +